In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae

J. H. Jorgensen, J. S. Redding, A. W. Howell

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

The in vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) was compared with the activities of five other orally absorbable antimicrobial agents against 100 clinical isolates of Haemophilus influenzae. Roxithromycin MICs were generally twofold to fourfold higher than those of erythromycin; the MIC for 90% of the strains for roxithromycin was 8 μg/ml.

Original languageEnglish (US)
Pages (from-to)921-922
Number of pages2
JournalAntimicrobial agents and chemotherapy
Volume29
Issue number5
DOIs
StatePublished - Jan 1 1986

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae'. Together they form a unique fingerprint.

  • Cite this